|
|
|
|
| LEADER |
03355nam a2200457 4500 |
| 001 |
ocn785407723 |
| 003 |
OCoLC |
| 005 |
20180501121956.0 |
| 006 |
m o d |
| 007 |
cr cn||||||||| |
| 008 |
120411s2012 cau ob 001 0 eng d |
| 040 |
|
|
|a OPELS
|b eng
|e pn
|c OPELS
|d E7B
|d N$T
|d CDX
|d OCLCQ
|d OCLCF
|d YDXCP
|d OCLCQ
|d RUQBL
|d OCLCQ
|d ESU
|d GrThAP
|
| 019 |
|
|
|a 787852042
|a 807366850
|
| 020 |
|
|
|a 9780123965486
|q (electronic bk.)
|
| 020 |
|
|
|a 0123965489
|q (electronic bk.)
|
| 020 |
|
|
|a 9780123972316
|q (electronic bk.)
|
| 020 |
|
|
|a 0123972310
|q (electronic bk.)
|
| 035 |
|
|
|a (OCoLC)785407723
|z (OCoLC)787852042
|z (OCoLC)807366850
|
| 050 |
|
4 |
|a QR189.2
|b .S96 2012
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615.3/72
|2 23
|
| 049 |
|
|
|a TEFA
|
| 245 |
0 |
0 |
|a Synthetic vaccines /
|c edited by Cornelis J.M. Melief.
|
| 260 |
|
|
|a San Diego, CA :
|b Academic Press,
|c ©2012.
|
| 300 |
|
|
|a 1 online resource (xiv, 260 pages).
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in Immunology ;
|v 114
|
| 520 |
|
|
|a Advances in Immunology, a long-established and highly respected publication, presents current developments as well as comprehensive reviews in immunology. Articles address the wide range of topics that comprise immunology, including molecular and cellular activation mechanisms, phylogeny and molecular evolution, and clinical modalities. Edited and authored by the foremost scientists in the field, each volume provides up-to-date information and directions for the future.
|
| 505 |
0 |
|
|a Nucleic acid adjuvants: towards an educated vaccine / Jasper G. van den Boorn, Winfried Barchet and Gunther Hartmann --Structure-based design for high-hanging vaccine fruits / Johannes P.M. Langedijk and Jaap W. Back -- Mechanisms of peptide vaccination in mouse models: tolerance, immunity and hyper-reactivity / Thorbald van Hall and Sjoerd H van der Burg -- Experience with synthetic vaccines for cancer and persistent virus infections in non-human primates and patients / Esther D. Quakkelaar and Cornelis J.M. Melief -- Malaria vaccine development using synthetic peptides as a technical platform / Giampietro Corradin, Nora Cespedes, Antonio Verdini, Andrey V. Kajava, Myriam Ařvalo and S̤crates Herrera -- Enhancing cancer immunotherapy by intracellular delivery of cell penetrating peptides and stimulation of pattern-recognition receptor signaling / Helen Y. Wang and Rong-Fu Wang -- TLR ligand-peptide conjugate vaccines: towards clinical application / Gijs GP Zom, Selina Khan, Dmitri V Filippov, Ferry Ossendorp -- Behaviour and function of Tissue-resident Memory T cells / Silvia Ariotti, John B. Haanen and Ton N. Schumacher -- Rational Design of Vaccines: Learning from Immune Evasion Mechanisms of Persistent Viruses and Tumors / Ramon Arens.
|
| 500 |
|
|
|a Includes index.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 650 |
|
0 |
|a Synthetic vaccines.
|
| 650 |
|
6 |
|a Vaccins synthétiques.
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Synthetic vaccines.
|2 fast
|0 (OCoLC)fst01141286
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Melief, Cornelius J. M.
|
| 830 |
|
0 |
|a Advances in immunology ;
|v 114.
|
| 856 |
4 |
0 |
|u https://www.sciencedirect.com/science/bookseries/00652776/114
|z Full Text via HEAL-Link
|
